Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Binding Mode Exploration of B1 Receptor Antagonists' by the Use of Molecular Dynamics and Docking Simulation-How Different Target Engagement Can Determine Different Biological Effects.
Gemei M, Talarico C, Brandolini L, Manelfi C, Za L, Bovolenta S, Liberati C, Vecchio LD, Russo R, Cerchia C, Allegretti M, Beccari AR. Gemei M, et al. Among authors: za l. Int J Mol Sci. 2020 Oct 16;21(20):7677. doi: 10.3390/ijms21207677. Int J Mol Sci. 2020. PMID: 33081372 Free PMC article.
Novel selective, potent naphthyl TRPM8 antagonists identified through a combined ligand- and structure-based virtual screening approach.
Beccari AR, Gemei M, Lo Monte M, Menegatti N, Fanton M, Pedretti A, Bovolenta S, Nucci C, Molteni A, Rossignoli A, Brandolini L, Taddei A, Za L, Liberati C, Vistoli G. Beccari AR, et al. Among authors: za l. Sci Rep. 2017 Sep 8;7(1):10999. doi: 10.1038/s41598-017-11194-0. Sci Rep. 2017. PMID: 28887460 Free PMC article.
Publisher Correction: Novel selective, potent naphthyl TRPM8 antagonists identified through a combined ligand- and structure-based virtual screening approach.
Beccari AR, Gemei M, Lo Monte M, Menegatti N, Fanton M, Pedretti A, Bovolenta S, Nucci C, Molteni A, Rossignoli A, Brandolini L, Taddei A, Za L, Liberati C, Vistoli G. Beccari AR, et al. Among authors: za l. Sci Rep. 2018 Mar 6;8(1):4250. doi: 10.1038/s41598-018-21902-z. Sci Rep. 2018. PMID: 29511237 Free PMC article.
P2X7 antagonists for CNS indications: recent patent disclosures.
Pevarello P, Bovolenta S, Tarroni P, Za L, Severi E, Torino D, Vitalone R. Pevarello P, et al. Among authors: za l. Pharm Pat Anal. 2017 Mar;6(2):61-76. doi: 10.4155/ppa-2016-0044. Epub 2017 Mar 1. Pharm Pat Anal. 2017. PMID: 28248151 Review.
The atypical receptor CCRL2 is required for CXCR2-dependent neutrophil recruitment and tissue damage.
Del Prete A, Martínez-Muñoz L, Mazzon C, Toffali L, Sozio F, Za L, Bosisio D, Gazzurelli L, Salvi V, Tiberio L, Liberati C, Scanziani E, Vecchi A, Laudanna C, Mellado M, Mantovani A, Sozzani S. Del Prete A, et al. Among authors: za l. Blood. 2017 Sep 7;130(10):1223-1234. doi: 10.1182/blood-2017-04-777680. Epub 2017 Jul 25. Blood. 2017. PMID: 28743719 Free article.
11 results